NR3C1 and prostate carcinoma: Building on this, pro-apoptotic effects of GR antagonism were demonstrated with cisplatin and gemcitabine in pancreatic cancer cells [6], paclitaxel in breast cancer cells [14, 23], carboplatin in ovarian cancer cells [15], and docetaxel in prostate cancer cells [24].